Literature DB >> 21278255

Antimicrobial activity of community-associated methicillin-resistant Staphylococcus aureus is caused by phenol-soluble modulin derivatives.

Hwang-Soo Joo1, Gordon Y C Cheung, Michael Otto.   

Abstract

Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) are causing an ongoing pandemic of mostly skin and soft tissue infections. The success of CA-MRSA as pathogens is due to a combination of antibiotic resistance with high virulence. In addition, it has been speculated that CA-MRSA strains such as the epidemic U.S. clone USA300 have increased capacity to colonize human epithelia, owing to bacteriocin-based bacterial interference. We here analyzed the molecular basis of antimicrobial activity detected in S. aureus strains, including those of the USA300 lineage. In contrast to a previous hypothesis, we found that this activity is not due to expression of a lantibiotic-type bacteriocin, but proteolytically processed derivatives of the phenol-soluble modulin (PSM) peptides PSMα1 and PSMα2. Notably, processed PSMα1 and PSMα2 exhibited considerable activity against Streptococcus pyogenes, indicating a role of PSMs in the interference of S. aureus strains with the competing colonizing pathogen. Furthermore, by offering a competitive advantage during colonization of the human body, the characteristically high production of PSMs in USA300 and other CA-MRSA strains may thus contribute not only to virulence but also the exceptional capacity of those strains to sustainably spread in the population, which so far has remained poorly understood.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21278255      PMCID: PMC3059065          DOI: 10.1074/jbc.M111.221382

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

1.  Analysis of genes involved in the biosynthesis of lantibiotic epidermin.

Authors:  N Schnell; G Engelke; J Augustin; R Rosenstein; V Ungermann; F Götz; K D Entian
Journal:  Eur J Biochem       Date:  1992-02-15

2.  The amino acid sequence of a gonococcal growth inhibitor from Staphylococcus haemolyticus.

Authors:  D C Watson; M Yaguchi; J G Bisaillon; R Beaudet; R Morosoli
Journal:  Biochem J       Date:  1988-05-15       Impact factor: 3.857

3.  Characterization of transposon mutants of biofilm-producing Staphylococcus epidermidis impaired in the accumulative phase of biofilm production: genetic identification of a hexosamine-containing polysaccharide intercellular adhesin.

Authors:  D Mack; M Nedelmann; A Krokotsch; A Schwarzkopf; J Heesemann; R Laufs
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

4.  Production, purification, and preliminary characterization of a gonococcal growth inhibitor produced by a coagulase-negative staphylococcus isolated from the urogenital flora.

Authors:  R Beaudet; J G Bisaillon; S A Saheb; M Sylvestre
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

5.  Bacterial pathogens modulate an apoptosis differentiation program in human neutrophils.

Authors:  Scott D Kobayashi; Kevin R Braughton; Adeline R Whitney; Jovanka M Voyich; Tom G Schwan; James M Musser; Frank R DeLeo
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-05       Impact factor: 11.205

6.  Structural gene isolation and prepeptide sequence of gallidermin, a new lanthionine containing antibiotic.

Authors:  N Schnell; K D Entian; F Götz; T Hörner; R Kellner; G Jung
Journal:  FEMS Microbiol Lett       Date:  1989-04       Impact factor: 2.742

7.  Cloning, characterization, and sequencing of an accessory gene regulator (agr) in Staphylococcus aureus.

Authors:  H L Peng; R P Novick; B Kreiswirth; J Kornblum; P Schlievert
Journal:  J Bacteriol       Date:  1988-09       Impact factor: 3.490

8.  Prepeptide sequence of epidermin, a ribosomally synthesized antibiotic with four sulphide-rings.

Authors:  N Schnell; K D Entian; U Schneider; F Götz; H Zähner; R Kellner; G Jung
Journal:  Nature       Date:  1988-05-19       Impact factor: 49.962

9.  Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance.

Authors:  Matthew T G Holden; Edward J Feil; Jodi A Lindsay; Sharon J Peacock; Nicholas P J Day; Mark C Enright; Tim J Foster; Catrin E Moore; Laurence Hurst; Rebecca Atkin; Andrew Barron; Nathalie Bason; Stephen D Bentley; Carol Chillingworth; Tracey Chillingworth; Carol Churcher; Louise Clark; Craig Corton; Ann Cronin; Jon Doggett; Linda Dowd; Theresa Feltwell; Zahra Hance; Barbara Harris; Heidi Hauser; Simon Holroyd; Kay Jagels; Keith D James; Nicola Lennard; Alexandra Line; Rebecca Mayes; Sharon Moule; Karen Mungall; Douglas Ormond; Michael A Quail; Ester Rabbinowitsch; Kim Rutherford; Mandy Sanders; Sarah Sharp; Mark Simmonds; Kim Stevens; Sally Whitehead; Bart G Barrell; Brian G Spratt; Julian Parkhill
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-22       Impact factor: 11.205

10.  Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule.

Authors:  R P Novick; H F Ross; S J Projan; J Kornblum; B Kreiswirth; S Moghazeh
Journal:  EMBO J       Date:  1993-10       Impact factor: 11.598

View more
  71 in total

Review 1.  Virulence strategies of the dominant USA300 lineage of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA).

Authors:  Lance R Thurlow; Gauri S Joshi; Anthony R Richardson
Journal:  FEMS Immunol Med Microbiol       Date:  2012-03-05

2.  The virulence regulator Agr controls the staphylococcal capacity to activate human neutrophils via the formyl peptide receptor 2.

Authors:  Dorothee Kretschmer; Nele Nikola; Manuela Dürr; Michael Otto; Andreas Peschel
Journal:  J Innate Immun       Date:  2011-11-08       Impact factor: 7.349

3.  Identification of a Human Skin Commensal Bacterium that Selectively Kills Cutibacterium acnes.

Authors:  Alan M O'Neill; Teruaki Nakatsuji; Asumi Hayachi; Michael R Williams; Robert H Mills; David J Gonzalez; Richard L Gallo
Journal:  J Invest Dermatol       Date:  2020-01-23       Impact factor: 8.551

4.  Phenol soluble modulin (PSM) variants of community-associated methicillin-resistant Staphylococcus aureus (MRSA) captured using mass spectrometry-based molecular networking.

Authors:  David J Gonzalez; Lisa Vuong; Isaiah S Gonzalez; Nadia Keller; Dominic McGrosso; John H Hwang; Jun Hung; Annelies Zinkernagel; Jack E Dixon; Pieter C Dorrestein; Victor Nizet
Journal:  Mol Cell Proteomics       Date:  2014-02-24       Impact factor: 5.911

5.  Novel phenol-soluble modulin derivatives in community-associated methicillin-resistant Staphylococcus aureus identified through imaging mass spectrometry.

Authors:  David J Gonzalez; Cheryl Y Okumura; Andrew Hollands; Roland Kersten; Kathryn Akong-Moore; Morgan A Pence; Cheryl L Malone; Jaclyn Derieux; Bradley S Moore; Alexander R Horswill; Jack E Dixon; Pieter C Dorrestein; Victor Nizet
Journal:  J Biol Chem       Date:  2012-02-27       Impact factor: 5.157

Review 6.  Phenol-soluble modulins and staphylococcal infection.

Authors:  Andreas Peschel; Michael Otto
Journal:  Nat Rev Microbiol       Date:  2013-09-10       Impact factor: 60.633

Review 7.  Current concepts on the virulence mechanisms of meticillin-resistant Staphylococcus aureus.

Authors:  Richard R Watkins; Michael Z David; Robert A Salata
Journal:  J Med Microbiol       Date:  2012-06-28       Impact factor: 2.472

Review 8.  Phenol-soluble modulins.

Authors:  Michael Otto
Journal:  Int J Med Microbiol       Date:  2013-12-01       Impact factor: 3.473

9.  Do amyloid structures formed by Staphylococcus aureus phenol-soluble modulins have a biological function?

Authors:  Yue Zheng; Hwang-Soo Joo; Vinod Nair; Katherine Y Le; Michael Otto
Journal:  Int J Med Microbiol       Date:  2017-09-01       Impact factor: 3.473

10.  Formyl-peptide receptor 2 governs leukocyte influx in local Staphylococcus aureus infections.

Authors:  Elisabeth Weiss; Dennis Hanzelmann; Beate Fehlhaber; Andreas Klos; Friederike D von Loewenich; Jan Liese; Andreas Peschel; Dorothee Kretschmer
Journal:  FASEB J       Date:  2017-08-30       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.